Journal of Indian Academy of Oral Medicine and Radiology, 2015 The immune-mediated oral mucosal lesions pose a challenge to the oral physicians owing to their preplexing diagnosis and management. Steroids are the first line of treatment for these diseases, but they have their limitations.
Bharati A Patil +2 more
doaj +1 more source
PHOTOPHERESIS IN THE COMPREHENSIVE TREATMENT OF UROGENITAL REACTIVE ARTHRITIS (REITER’S DISEASE)
Alʹmanah Kliničeskoj Mediciny, 2016 The article reports successful use of extracorporeal photochemotherapy (photopheresis) in the comprehensive treatment of 9 patients with urogenital reactive arthritis (Reiter’s disease).
M. S. Petrova +2 more
doaj +1 more source
Guidelines on the use of extracorporeal photopheresis [PDF]
, 2013 Peer ...
Arenberger, P. +39 more
core +1 more source
Regulatory T-cells in chronic graft-versus-host disease following extracorporeal photopheresis: correlation with skin and global organ responses, and ability to taper steroids [PDF]
, 2017 Background: Induction of immune tolerance by an increase in regulatory T (Treg) cells after extracorporeal photopheresis (ECP) is thought to contribute to how ECP exerts its therapeutic effect in patients with chronic graft-versus-host disease (cGvHD ...
Denney, H.A. +4 more
core +1 more source
Extracorporeal photoimmunotherapy-photopheresis
Frontiers in Bioscience, 2009 Extracorporeal photoimmunotherapy-photopheresis (ECP) is an immunomodulatory therapy, which basically consists of separating the patient's leucocyte rich plasma from the red blood cell fraction, followed by extracorporeal administration of a photosensitizer and UVA light prior to reinfusion of the treated cells.
Theresa, Dani, Robert, Knobler
openaire +2 more sources
Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sézary syndrome [PDF]
, 2021 Sézary syndrome (SS) is a rare, leukemic type of cutaneous T-cell lymphoma (CTCL), for which extracorporeal photopheresis (ECP) is a first-line therapy. Reliable biomarkers to objectively monitor the response to ECP in patients with SS are missing.
Bobrowicz, Malgorzata +9 more
core +4 more sources
Extracorporeal Photopheresis versus Anticytokine Therapy as a Second-Line Treatment for Steroid-Refractory Acute GVHD: A Multicenter Comparative Analysis [PDF]
, 2011 The optimal therapy for steroid-refractory (SR) acute graft-versus-host disease (aGVHD) is undefined. We studied patients with SR aGVHD, comparing extracorporeal photopheresis (ECP; n = 57) and anticytokine therapy (n = 41). In multivariate analyses, ECP,
Madan Jagasia +29 more
core +1 more source
Non-infectious pulmonary complications of hematopoietic stem cell transplantation [PDF]
, 2014 Noninfectious pulmonary complications of hematopoietic stem cell transplant are currently more prevalent than infectious complications. Unfortunately, the pathophysiology basis is not completely understood.
Baloglu, Orkun +2 more
core +1 more source
Clinical Results of Extracorporeal Photopheresis [PDF]
Transfusion Medicine and Hemotherapy, 2012 Extracorporeal photopheresis (ECP) is a combination of leukapheresis and photodynamic therapy in which blood is treated with photoactivable drugs which are then activated with ultraviolet light and re-infused to the patient. It has been used successfully for more than 30 years in the treatment of erythrodermic cutaneous T-cell lymphoma (CTCL) and over ...
Nina, Worel, Gerda, Leitner
openaire +2 more sources
Extracorporeal photopheresis in solid organ transplantation
Alʹmanah Kliničeskoj Mediciny, 2020 Despite the use of up-to-date immunosuppressive agents, graft rejection episodes are quite common and pose a serious threat to thousands of solid organ recipients.
A. V. Kildyushevsky +4 more
doaj +1 more source